相关实验视频

Updated: Jul 10, 2025

Colony Forming Cell CFC Assay for Human Hematopoietic Cells

Colony Forming Cell CFC Assay for Human Hematopoietic Cells

Published on: December 18, 2010

循环混合细胞的标志循环混合细胞的标志

Ranish K Patel¹, Michael Parappilly², Shahrose Rahman¹

¹Department of Surgery, Oregon Health & Science University, Portland, OR, USA.

Results and problems in cell differentiation

|November 23, 2023

概括

新型瘤免疫混合细胞通过结合癌症和免疫细胞的特征来驱动癌症转移. 了解这些混合细胞是改善癌症预后和开发新疗法的关键.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

转移是癌症死亡的主要原因,但其潜在机制尚未完全理解.
一种由瘤和免疫细胞融合而形成的新型杂交细胞种群已被确定.
这些瘤免疫杂交细胞在原发性瘤,血液和转移性部位中发现.

结论:

瘤免疫混合细胞对癌症转移和患者的结果有显著的贡献.
对这些细胞的进一步研究有可能改善癌症预后.
针对混合细胞的发育和传播可能会导致新的治疗策略.

关键词:

细胞融合是细胞的融合.癌症的标志是癌症的标志.巨细胞是一个巨细胞.转移转移转移转移新塑性-免疫细胞混合体.瘤是一个瘤.

更多相关视频

Isolation of Murine Embryonic Hemogenic Endothelial Cells

Isolation of Murine Embryonic Hemogenic Endothelial Cells

Published on: June 17, 2016

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis

Published on: April 10, 2012

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...